Blood Cell-Bound C4d as a Marker of Complement Activation in Patients With the Antiphospholipid Syndrome

Antiphospholipid syndrome (APS) is a chronic and disabling condition characterized by recurrent thrombosis and miscarriages mediated by antibodies against phospholipid-binding proteins (aPL), such as beta(2)glycoprotein I (β(2)GPI). Complement is involved in APS animal models and complement deposits...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Front Immunol
Hauptverfasser: Lonati, Paola Adele, Scavone, Mariangela, Gerosa, Maria, Borghi, Maria Orietta, Pregnolato, Francesca, Curreli, Daniele, Podda, Gianmarco, Femia, Eti Alessandra, Barcellini, Wilma, Cattaneo, Marco, Tedesco, Francesco, Meroni, Pier Luigi
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2019
Schlagworte:
Immunology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6474283/
https://ncbi.nlm.nih.gov/pubmed/31031764
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.00773
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge